Cargando…

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Active specific immunotherapy is a promising field in cancer research. N-glycolyl (NGc) gangliosides, and particularly NGcGM3, have received attention as a privileged target for cancer therapy. Many clinical trials have been performed with the anti-NGc-containing gangliosides anti-idiotype monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez, Luis E., Gabri, Mariano R., Guthmann, Marcelo D., Gomez, Roberto E., Gold, Silvia, Fainboim, Leonardo, Gomez, Daniel E., Alonso, Daniel F.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965427/ https://www.ncbi.nlm.nih.gov/pubmed/21048926 http://dx.doi.org/10.1155/2010/814397

Ejemplares similares

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3
por: Palomo, Addys González, et al.
Publicado: (2018)

CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
por: Cribioli, Elisabetta, et al.
Publicado: (2022)

Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients
por: de la Torre, Ana, et al.
Publicado: (2016)

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3
por: Guthmann, Marcelo D., et al.
Publicado: (2013)

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012)

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
por: Scursoni, Alejandra M., et al.
Publicado: (2011)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012)

Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications
por: Palomo, Addys González, et al.
Publicado: (2016)

Cranial multineuritis associated with anti-GM2 ganglioside antibodies after SARS-CoV-2 infection
por: Torres Gómez, Antonio, et al.
Publicado: (2023)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

NGC 1068 Workshop
por: Gallimore,, et al.
Publicado: (1996)

Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011)

Secondary ganglioside GM2 accumulation in mucopolysaccharidoses
por: Sandhoff, Konrad
Publicado: (2021)

Ganglioside GM1 and the Central Nervous System
por: Guo, Zhongwu
Publicado: (2023)

Extinction in NGC 628 and NGC 2403 derived from Paschen and Balmer lines
por: Petersen, L, et al.
Publicado: (1995)

Discovery and implications of very low metal abundances in NGC 1404 and NGC 4374
por: Loewenstein, M, et al.
Publicado: (1994)

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010)

GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018)

Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)

Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

Spiral structure in the circumnuclear disk at the center of NGC 4258
por: Maoz, E
Publicado: (1995)

Far UV study on the non-thermal activity in the narrow line galaxies NGC 4507 and NGC 5506
por: Bergeron, J, et al.
Publicado: (1981)

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
por: Alpaugh, Melanie, et al.
Publicado: (2017)

Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
por: Kim, Jong Kuk, et al.
Publicado: (2018)

Anti-inflammatory role of GM1 and other gangliosides on microglia
por: Galleguillos, Danny, et al.
Publicado: (2022)

The cytoprotective role of GM1 ganglioside in Huntington disease cells
por: Hart, Hannah S., et al.
Publicado: (2022)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

NGC 1809 and PKS 0502-696
por: West, R M
Publicado: (1979)

On the core-halo structure of NGC 604
por: Melnick, Yu M
Publicado: (1980)

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System
por: Blanco, Rancés, et al.
Publicado: (2011)

GM(1) Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
por: Amaro, Mariana, et al.
Publicado: (2016)

Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
por: Finsterwald, Charles, et al.
Publicado: (2021)

Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
por: Inamori, Kei-ichiro, et al.
Publicado: (2022)

The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
por: Sonnino, Sandro
Publicado: (2023)

Is the edge-on galaxy NGC 4762 actually barred?
por: Wozniak, H
Publicado: (1994)

The interstellar medium in the Seyfert galaxy NGC 7172
por: Anupama, G C, et al.
Publicado: (1994)

The nature of the low-luminosity AGN in NGC 3147
por: Ptak, A, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_ac8lilied4t1rn74n021p0nfrm